AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Durken, M von Finkenstein, FG Erttmann, R Kabisch, H Schafhausen, P Jaburg, N Loliger, C Zander, AR
Citation: N. Kroger et al., Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors, ANN HEMATOL, 80(4), 2001, pp. 209-215

Authors: Kroger, N Zabelina, T Sonnenberg, S Kruger, W Renges, H Stute, N Finkenstein, F Mayer, U Holstein, K Fiedler, W Colberg, H Sonnen, R Kuse, R Braumann, D Metzner, B del Valle, F Erttmann, R Kabisch, H Zander, AR
Citation: N. Kroger et al., Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia, BONE MAR TR, 26(7), 2000, pp. 711-716

Authors: Schilling, FH Berthold, F Erttmann, R Michaelis, J Spix, C Sander, J Schwarz, K Treuner, J
Citation: Fh. Schilling et al., Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: Interim results, MED PED ONC, 35(6), 2000, pp. 701-704

Authors: Kroger, N Zeller, W Hassan, HT Kruger, W Renges, H Russmann, B Fuchs, N Rauhoft, C Gutensohn, K Loliger, C Erttmann, R Kuhnl, P Zander, AR
Citation: N. Kroger et al., Steady-state mobilization of peripheral blood progenitor cells by cytokines alone in patients with solid tumors or hematological malignancies, INFUSIONSTH, 26(2), 1999, pp. 85-90

Authors: Fuchs, J Bode, U von Schweinitz, D Weinel, P Erttmann, R Harms, D Mildenberger, D
Citation: J. Fuchs et al., Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma:A report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HE 94, KLIN PADIAT, 211(4), 1999, pp. 305-309

Authors: Schmitt, C David, K Hiller, J Schrum, J Bredehorst, R Vogel, CW Loliger, C Erttmann, R
Citation: C. Schmitt et al., Natural human IgM antibodies in neuroblastoma therapy: Preliminary resultsfrom a phase I/II therapy study, KLIN PADIAT, 211(4), 1999, pp. 314-318

Authors: Zander, AR Zabelina, T Kroger, N Renges, H Kruger, W Loliger, C Durken, M Stockschlader, M de Wit, M Wacker-Backhaus, G Bielack, S Jaburg, N Russmann, B Erttmann, R Kabisch, H
Citation: Ar. Zander et al., Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow, BONE MAR TR, 23(9), 1999, pp. 889-893

Authors: Kruger, W Russmann, B Kroger, N Salomon, C Ekopf, N Elsner, HA Kaulfers, PM Mack, D Fuchs, N Durken, M Kabisch, H Erttmann, R Zander, AR
Citation: W. Kruger et al., Early infections in patients undergoing bone marrow or blood stem cell transplantation - a 7 year single centre investigation of 409 cases, BONE MAR TR, 23(6), 1999, pp. 589-597

Authors: David, K Ollert, MW Vollmert, C Heiligtag, S Eickhoff, B Erttmann, R Bredehorst, R Vogel, CW
Citation: K. David et al., Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a M-r 260,000 antigen, CANCER RES, 59(15), 1999, pp. 3768-3775

Authors: Durken, M Horstmann, M Bieling, P Erttmann, R Kabisch, H Loliger, C Schneider, EM Hellwege, HH Kruger, W Kroger, N
Citation: M. Durken et al., Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients, BR J HAEM, 106(4), 1999, pp. 1052-1058

Authors: Kroger, N Kruger, W Wacker-Backhaus, G Hegewisch-Becker, S Stockschlader, M Fuchs, N Russmann, B Renges, H Durken, M Bielack, S de Wit, M Schuch, G Bartels, H Braumann, D Kuse, R Kabisch, H Erttmann, R Zander, AR
Citation: N. Kroger et al., Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia, BONE MAR TR, 22(11), 1998, pp. 1029-1033
Risultati: 1-11 |